ReP USP - Resultado da busca

Artigo de periodico
Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin (2020)
Amarenco, Pierre; Denison, Hans; Evans, Scott R.; Himmelmann, Anders; James, Stefan; Knutsson, Mikael; Ladenvall, Per; Molina, Carlos Augusto Fernandes ; Wang, Yongjun; Johnston, S. Claiborne
Source: Stroke. Unidade: FMRP
Subjects: ENVELHECIMENTO, ARTERIOSCLEROSE, DOENÇAS CEREBRAIS, DOENÇAS CARDIOVASCULARES, ISQUEMIA, FARMACOTERAPIA, ÍNDICE DE GRAVIDADE DA DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARENCO, Pierre et al. Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin. Stroke, v. 51, n. 12, p. 3504-3513, 2020Tradução . . Disponível em: https://doi.org/10.1161/STROKEAHA.120.032239. Acesso em: 11 nov. 2024.
APA
Amarenco, P., Denison, H., Evans, S. R., Himmelmann, A., James, S., Knutsson, M., et al. (2020). Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin. Stroke, 51( 12), 3504-3513. doi:10.1161/STROKEAHA.120.032239
NLM
Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CAF, Wang Y, Johnston SC. Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin [Internet]. Stroke. 2020 ; 51( 12): 3504-3513.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1161/STROKEAHA.120.032239
Vancouver
Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CAF, Wang Y, Johnston SC. Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin [Internet]. Stroke. 2020 ; 51( 12): 3504-3513.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1161/STROKEAHA.120.032239
Artigo de periodico
Ticagrelor in patients with stable coronary disease and diabetes (2019)
Steg, P. Gabriel; Bhatt, Deepak L; Simon, Tabassome; Fox, Kim; Mehta, Shamir R; Harrington, Robert A; Held, Claes; Andersson, Marielle; Himmelmann, Anders; Nicolau, José Carlos
Source: New england journal of medicine. Unidade: FM
Subjects: CORONARIOPATIA, DIABETES MELLITUS, ADENOSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STEG, P. Gabriel et al. Ticagrelor in patients with stable coronary disease and diabetes. New england journal of medicine, v. 381, n. 14, p. 1309-1320, 2019Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1908077. Acesso em: 11 nov. 2024.
APA
Steg, P. G., Bhatt, D. L., Simon, T., Fox, K., Mehta, S. R., Harrington, R. A., et al. (2019). Ticagrelor in patients with stable coronary disease and diabetes. New england journal of medicine, 381( 14), 1309-1320. doi:10.1056/NEJMoa1908077
NLM
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Nicolau JC. Ticagrelor in patients with stable coronary disease and diabetes [Internet]. New england journal of medicine. 2019 ; 381( 14): 1309-1320.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1056/NEJMoa1908077
Vancouver
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Nicolau JC. Ticagrelor in patients with stable coronary disease and diabetes [Internet]. New england journal of medicine. 2019 ; 381( 14): 1309-1320.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1056/NEJMoa1908077
Artigo de periodico
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study (2019)
Bhatt, Deepak L; Fox, Kim; Harrington, Robert A; Leiter, Lawrence A; Mehta, Shamir R; Simon, Tabassome; Andersson, Marielle; Himmelmann, Anders; Ridderstrale, Wilhelm; Nicolau, José Carlos
Source: Clinical cardiology. Unidade: FM
Subjects: SÍNDROME CORONARIANA AGUDA, DIABETES MELLITUS, VASOS CORONÁRIOS, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHATT, Deepak L et al. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study. Clinical cardiology, v. 42, n. 5, p. 498-505, 2019Tradução . . Disponível em: https://doi.org/10.1002/clc.23164. Acesso em: 11 nov. 2024.
APA
Bhatt, D. L., Fox, K., Harrington, R. A., Leiter, L. A., Mehta, S. R., Simon, T., et al. (2019). Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study. Clinical cardiology, 42( 5), 498-505. doi:10.1002/clc.23164
NLM
Bhatt DL, Fox K, Harrington RA, Leiter LA, Mehta SR, Simon T, Andersson M, Himmelmann A, Ridderstrale W, Nicolau JC. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study [Internet]. Clinical cardiology. 2019 ; 42( 5): 498-505.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/clc.23164
Vancouver
Bhatt DL, Fox K, Harrington RA, Leiter LA, Mehta SR, Simon T, Andersson M, Himmelmann A, Ridderstrale W, Nicolau JC. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study [Internet]. Clinical cardiology. 2019 ; 42( 5): 498-505.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/clc.23164
Artigo de periodico
The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial (2014)
Husted, Steen; James, Stefan K.; Bach, Richard G.; Becker, Richard C.; Budaj, Andrzej; Heras, Magda; Himmelmann, Anders; Horrow, Jay; Katus, Hugo A.; Lassila, Riita; Morais, Joao; Nicolau, José C.; Steg, Gabriel; Storey, Robert F.; Wojdyla, Daniel; Wallentin, Lars
Source: European heart journal. Unidade: FM
Subjects: TROMBOSE, SEXO, SÍNDROME CORONARIANA AGUDA, PLAQUETAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUSTED, Steen et al. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. European heart journal, v. 35, n. 23, p. 1541-1550, 2014Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehu075. Acesso em: 11 nov. 2024.
APA
Husted, S., James, S. K., Bach, R. G., Becker, R. C., Budaj, A., Heras, M., et al. (2014). The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. European heart journal, 35( 23), 1541-1550. doi:10.1093/eurheartj/ehu075
NLM
Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg G, Storey RF, Wojdyla D, Wallentin L. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial [Internet]. European heart journal. 2014 ; 35( 23): 1541-1550.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1093/eurheartj/ehu075
Vancouver
Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg G, Storey RF, Wojdyla D, Wallentin L. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial [Internet]. European heart journal. 2014 ; 35( 23): 1541-1550.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1093/eurheartj/ehu075

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em